C333H, a Novel PPARalpha/gamma Dual Agonist, Has Beneficial Effects on Insulin Resistance and Lipid Metabolism1

Acta Pharmacologica Sinica - United Kingdom
doi 10.1111/j.1745-7254.2006.00263.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature


Related search